133 related articles for article (PubMed ID: 15167273)
1. Partial agonism of taprostene at prostanoid IP receptors in vascular preparations from guinea-pig, rat, and mouse.
Chan KM; Jones RL
J Cardiovasc Pharmacol; 2004 Jun; 43(6):795-807. PubMed ID: 15167273
[TBL] [Abstract][Full Text] [Related]
2. Distinction between relaxations induced via prostanoid EP(4) and IP(1) receptors in pig and rabbit blood vessels.
Jones RL; Chan K
Br J Pharmacol; 2001 Sep; 134(2):313-24. PubMed ID: 11564649
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the agonist activity of prostacyclin analogues on prostanoid EP4 receptors using GW 627368 and taprostene: evidence for species differences.
Jones RL; Chan KM
Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):289-99. PubMed ID: 15763441
[TBL] [Abstract][Full Text] [Related]
4. The mechanisms of enhancement and inhibition of field stimulation responses of guinea-pig vas deferens by prostacyclin analogues.
Tam FS; Chan K; Borreau JP; Jones RL
Br J Pharmacol; 1997 Aug; 121(7):1413-21. PubMed ID: 9257922
[TBL] [Abstract][Full Text] [Related]
5. Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum.
Lawrence RA; Jones RL; Wilson NH
Br J Pharmacol; 1992 Feb; 105(2):271-8. PubMed ID: 1559125
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
7. Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery.
Jones RL; Qian YM; Wise H; Wong HN; Lam WL; Chan HW; Yim AP; Ho JK
J Cardiovasc Pharmacol; 1997 Apr; 29(4):525-35. PubMed ID: 9156364
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.
Lydford SJ; McKechnie KC; Dougall IG
Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337
[TBL] [Abstract][Full Text] [Related]
9. Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery.
Qian YM; Jones RL; Chan KM; Stock AI; Ho JK
Br J Pharmacol; 1994 Oct; 113(2):369-74. PubMed ID: 7834185
[TBL] [Abstract][Full Text] [Related]
10. Non-prostanoid prostacyclin mimetics as neuronal stimulants in the rat: comparison of vagus nerve and NANC innervation of the colon.
Rudd JA; Qian Ym; Tsui KK; Jones RL
Br J Pharmacol; 2000 Feb; 129(4):782-90. PubMed ID: 10683203
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of rat colon contractility by prostacyclin (IP-) receptor agonists: involvement of NANC neurotransmission.
Qian YM; Jones RL
Br J Pharmacol; 1995 May; 115(1):163-71. PubMed ID: 7544196
[TBL] [Abstract][Full Text] [Related]
12. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
13. In vitro pharmacological characterization of the prostanoid receptor population in the non-pregnant porcine myometrium.
Cao J; Shayibuzhati M; Tajima T; Kitazawa T; Taneike T
Eur J Pharmacol; 2002 May; 442(1-2):115-23. PubMed ID: 12020689
[TBL] [Abstract][Full Text] [Related]
14. MaxiK channel-mediated relaxation of guinea-pig aorta following stimulation of IP receptor with beraprost via cyclic AMP-dependent and -independent mechanisms.
Yamaki F; Kaga M; Horinouchi T; Tanaka H; Koike K; Shigenobu K; Toro L; Tanaka Y
Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):538-50. PubMed ID: 11770009
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein.
Lawrence RA; Jones RL
Br J Pharmacol; 1992 Apr; 105(4):817-24. PubMed ID: 1324050
[TBL] [Abstract][Full Text] [Related]
16. Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI2 analogues in rat tail artery: Evidence for Gi/o modulation via EP3 receptors.
Orie NN; Clapp LH
Eur J Pharmacol; 2011 Mar; 654(3):258-65. PubMed ID: 21185823
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a prostanoid EP3-receptor in guinea-pig aorta: partial agonist action of the non-prostanoid ONO-AP-324.
Jones RL; Qian YM; Chan KM; Yim AP
Br J Pharmacol; 1998 Nov; 125(6):1288-96. PubMed ID: 9863659
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery.
Baxter GS; Clayton JK; Coleman RA; Marshall K; Sangha R; Senior J
Br J Pharmacol; 1995 Sep; 116(1):1692-6. PubMed ID: 8564239
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of the single isomer, esuberaprost (beraprost-314d) on pulmonary vascular tone, IP receptors and human smooth muscle proliferation in pulmonary hypertension.
Shen L; Patel JA; Norel X; Moledina S; Whittle BJ; von Kessler K; Sista P; Clapp LH
Biochem Pharmacol; 2019 Aug; 166():242-252. PubMed ID: 31158340
[TBL] [Abstract][Full Text] [Related]
20. Activation of prostanoid EP receptors by prostacyclin analogues in rabbit iliac artery: implications for anti-restenotic potential.
McCormick C; Jones RL; Kennedy S; Wadsworth RM
Eur J Pharmacol; 2010 Sep; 641(2-3):160-7. PubMed ID: 20450909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
